COVID-19 works with bacteria to increase disease severity in obesity and diabetes

A review of mechanisms linking obesity and diabetes to COVID-19 suggests that interactions between the virus and existing bacterial conditions could explain disease severity
15-Sep-2020 5:50 PM EDT, by eLife

Newswise — The combined effects of the body's microbiota working together with COVID-19 in the lungs could explain the severity of the disease in people with obesity and diabetes, according to a new article published today in eLife.

The review offers important mechanistic insights into why people with obesity and diabetes seem to be at increased risk of developing severe acute respiratory syndrome (SARS) after infection with the COVID-19 virus, and more often require hospitalisation and ventilation.

"There is rapidly emerging evidence highlighting obesity and type 2 diabetes as key risk factors linked to severity of COVID-19 infections in all ethnic groups, but the detailed underlying connections with these risk factors remain largely unknown," says author Philipp Scherer, Professor at the Department of Internal Medicine, and Director of the Touchstone Diabetes Center, at the University of Texas Southwestern Medical Center, Dallas, US. "There is a paradox that people with obesity and diabetes are generally known to recover better from lung conditions than others. So, what is it about COVID-19 that makes this group of people more susceptible?"

In their article, Scherer and his coauthors revisit the factors and disease pathways that connect obesity and diabetes to the severity of COVID-19 infection. The mechanisms can be roughly divided into two groups: those connected with the ACE2 receptor, and those providing an interaction between COVID-19 and pre-existing bacterial conditions.

ACE2 resides on the surface of many cells in the human body and is involved in regulating fluid volumes, blood pressure and the function of blood vessels. It is also used by COVID-19 to enter human cells. One theory is that increased amounts of ACE2 in people with obesity or diabetes makes it easier for the virus to enter cells and increases the viral load - an important factor in determining disease severity. Alternatively, increased shedding of ACE2 in people with obesity causes it to move to the lungs, where the virus can use it.

Another factor known to be influential in the progression of lung diseases is our body's microbiota. We carry more than 100 trillion bacteria in our body - outnumbering the number of our own cells. People with obesity and diabetes are thought to suffer from a body-wide dissemination of bacteria and the substances they produce, which in turn causes low-level continuous inflammation in different tissues.

The team considered how host bacteria might influence COVID-19 severity. One potential culprit is the lipopolysaccharides (LPS) that bacteria produce, which have been shown to cooperate with other coronaviruses to induce SARS in pigs. It is possible that these LPS molecules join forces with COVID-19 in humans and trigger a chain of events that causes healthy tissue to transform into scarred tissue - as COVID-19 does in the lungs.

"While all of these potential mechanisms can contribute to the severity of COVID-19, we believe that one of them plays the predominant role, and that this must be present not only in obese and diabetic patients, but also in other groups of increased risk in COVID-19," Scherer explains.

The authors propose that a combined deficiency in ACE2 caused by COVID-19, together with obesity or diabetes, leads to impaired gut barrier function, allowing bacteria and their toxins to leak into the circulation. In the lungs, these bacteria and toxins work with the virus to cause more severe lung injury than either would do alone.

"Our theory is supported by experiments showing that the combination of bacterial and viral infection can lead to a 'cytokine storm' - an extreme inflammatory reaction - which is a hallmark of COVID-19", Scherer concludes. "Moreover, the involvement of viral-bacterial interactions can also explain the increased risk of severe COVID-19 seen in older people, those with heart disease and in some ethnic groups."

###

 

About eLife

eLife is a non-profit organisation created by funders and led by researchers. Our mission is to accelerate discovery by operating a platform for research communication that encourages and recognises the most responsible behaviours. We work across three major areas: publishing, technology and research culture. We aim to publish work of the highest standards and importance in all areas of biology and medicine, while exploring creative new ways to improve how research is assessed and published. We also invest in open-source technology innovation to modernise the infrastructure for science publishing and improve online tools for sharing, using and interacting with new results. eLife receives financial support and strategic guidance from the Howard Hughes Medical Institute, the Knut and Alice Wallenberg Foundation, the Max Planck Society and Wellcome. Learn more at https://elifesciences.org/about.

To read the latest research in Medicine published in eLife, visit https://elifesciences.org/subjects/medicine.

SEE ORIGINAL STUDY




Filters close

Showing results

110 of 3386
Released: 24-Sep-2020 11:45 AM EDT
How the Loss of Black-Owned Doctors’ Offices May Worsen Health Disparities
Rutgers University-New Brunswick

Rutgers New Jersey Medical School experts discuss how the loss of Black-Owned doctors’ offices could affect primary care access in minority communities and what impact the COVID-19 pandemic is having in those communities.

Released: 24-Sep-2020 11:15 AM EDT
Preparing for asthma attacks during a pandemic
University of Texas Health Science Center at Houston

Cooler weather, pumpkins, and falling leaves – all things that kick off the most wonderful time of year, the holiday season. But for asthma sufferers, this could mean trouble because experts see an increase in asthma attacks toward the end of September.

Newswise: Double-lung transplant for COVID-19 patient performed by team of UTHealth physicians
Released: 24-Sep-2020 11:10 AM EDT
Double-lung transplant for COVID-19 patient performed by team of UTHealth physicians
University of Texas Health Science Center at Houston

Just 12 hours after undergoing a double-lung transplant, 70-year-old Francisco Medellin was sitting up in a chair pushing bike pedals – a seemingly simple act that was the culmination of hard work by a dedicated multidisciplinary team from McGovern Medical School at The University of Texas Health Science Center at Houston (UTHealth).

Newswise: Antibodies protect against wide range of influenza B virus strains
22-Sep-2020 11:50 AM EDT
Antibodies protect against wide range of influenza B virus strains
Washington University in St. Louis

Researchers have identified two antibodies that protect mice against lethal infections of influenza B virus, report scientists at Washington University School of Medicine in St. Louis and Icahn School of Medicine at Mount Sinai. Together with an antibody that targets the other major kind of influenza viruses that infect people — influenza A — these antibodies potentially could form the basis of a broad-spectrum flu drug that could treat almost all flu cases.

Released: 24-Sep-2020 10:45 AM EDT
Uncovering a ‘suPAR’ culprit behind kidney injury in COVID-19
Michigan Medicine - University of Michigan

A new observational study finds patients in the hospital for COVID-19 have high levels of soluble urokinase receptor (suPAR), an immune-derived pathogenic protein that is strongly predictive of kidney injury.

Released: 24-Sep-2020 10:35 AM EDT
Climate pledges 'like tackling COVID-19 without social distancing'
University of Exeter

Current global pledges to tackle climate change are the equivalent of declaring a pandemic without a plan for social distancing, researchers say.

Released: 24-Sep-2020 10:10 AM EDT
Rebound or Permanent Slump? Possible Impacts of US COVID-19 Fiscal Policies
University of Virginia Darden School of Business

Fiscal policy is a powerful tool to combat economic downturns, but the results depend on decreasing inequality, an imperative to the efficacy of fiscal multipliers. As COVID-19 cases rise, new research offers insights into which fiscal policies may bolster the economy — and the other options, which may have long-term ramifications.

access_time Embargo lifts in 2 days
Embargo will expire: 24-Sep-2020 2:00 PM EDT Released to reporters: 24-Sep-2020 9:25 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 24-Sep-2020 2:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 24-Sep-2020 5:05 AM EDT
Many Americans continue to maintain unhealthy lifestyle habits during COVID-19; overeating, alcohol drinking and marijuana use increase while exercise declines, reports USC Center for the Digital Future
USC Annenberg School for Communication and Journalism

After more than six months of living in a pandemic, large percentages of Americans continue to indulge in unhealthy lifestyle habits, including overeating and increased use of alcohol and marijuana — all while many are exercising less, according to a study of the cultural impact of COVID-19 conducted by the USC Center for the Digital Future (CDF).

Newswise: Houston Methodist COVID-19 study shows rapid spread and potential for mutant viruses
Released: 23-Sep-2020 4:55 PM EDT
Houston Methodist COVID-19 study shows rapid spread and potential for mutant viruses
Houston Methodist

Molecular analysis of COVID-19’s powerful second wave in Houston shows a mutated virus strain linked to higher transmission and infection rates than the coronavirus strains that caused Houston’s first wave. Gene sequencing results from 5,085 COVID-positive patients tested at Houston Methodist since early March show a virus capable of adapting, surviving and thriving – making it more important than ever for physician scientists to understand its evolution as they work to discover effective vaccines and therapies.


Showing results

110 of 3386

close
0.7937